FDA clears Corvention’s KardiaPSI Balloon Catheter as structural heart tools get more specialized
Calcified aortic valves need force and control. Corvention’s KardiaPSI clearance tests whether niche BAV tools can scale clinically.
Can Reprieve Cardiovascular’s FASTR data change acute heart failure decongestion?
Heart failure care needs faster decongestion without kidney harm. Reprieve’s FASTR data now face the pivotal trial test.
What Orchestra BioMed Holdings, Inc.’s AVIM strategy reveals about the future of hypertension device innovation
FDA backing boosts AVIM therapy momentum. Discover how Orchestra BioMed Holdings, Inc. is shaping the future of hypertension treatment.
Why Abbott’s Ultreon 3.0 could reshape stent planning in complex coronary disease
AI can now guide coronary imaging in real time. Abbott’s Ultreon 3.0 puts precision PCI closer to routine clinical workflow.
Could Reflow Medical’s new Cora microcatheters fix a hidden pain point in complex PCI?
Find out how Reflow Medical’s Cora Flex and Cora Force launch could reshape complex coronary intervention workflows.
Will the TricValve pivotal trial finally solve the unmet needs in severe tricuspid regurgitation?
P&F Products and Features GmbH, the Austria-based cardiovascular device innovator, has secured approval from the U.S. Food and Drug Administration to initiate the TRICAV II pivotal clinical trial. The study will evaluate the TricValve Transcatheter Bicaval Valve System for severe tricuspid regurgitation, aiming to provide a minimally invasive option for patients who currently have no […]